Not from my understanding. The report just showed how Bisantrene could possibly be used for a more targeted treatment which means you can have lower dose, less side effects, and better efficacy.
The reports great, but isn't an additional drug to be used in combo broadly like the current proposed trials.
We've been told they have found synergy with an already approved drug for the upcoming combo trials, but we haven't been told what that drug is. Well as far as I was aware anyway.
IMO, DYOR, etc
RAC - Charts & Price Action, page-20
-
- There are more pages in this discussion • 21,560 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |